Hyperthermia Cancer Treatment Market

Hyperthermia Cancer Treatment Market Outlook (2024 to 2034)

The global hyperthermia cancer treatment market size is set to reach US$ 158.5 million in 2024. Over the assessment period, demand for hyperthermia cancer treatment is projected to increase at 6.0% CAGR. By 2034, the overall market valuation is anticipated to total US$ 285.1 million.

Microwave hyperthermia devices remain the most widely used device type owing to their multiple advantages. The target segment is set to hold a value share of 39.7% by 2034. On the other hand, ultrasound hyperthermia device sales are expected to record a higher CAGR of 6.3%.

Hyperthermia cancer treatment or thermotherapy is gaining immense traction in cancer management globally. It uses heat to damage and kill cancer cells. As a result, its demand will rise significantly with increasing cancer cases.

There are generally three type of hyperthermia treatments. These include local hyperthermia, regional hyperthermia, and whole-body hyperthermia.

Hyperthermia is mostly used in combination with other cancer treatments like radiation therapy and chemotherapy. It can also be used with gene therapy and is effective in treating tumors that are difficult to reach with surgery or radiation therapy.

Growing adoption of hyperthermia treatments to treat cancers like melanoma and sarcomas is expected to boost growth of the hyperthermia cancer treatment market. Although hyperthermia is not a perfect cure for cancer, it can help to control and improve symptoms.

As per the National Cancer Institute (NCI), hyperthermia can shrink tumors and damage cancer cells, usually with minimal injury to normal tissues. Hence, growing preference for minimally invasive or non-invasive cancer treatments with lesser side effects will uplift demand for hyperthermia therapy.

Top players are focusing on developing advanced hyperthermia with additional features. They are also forming partnerships and alliances with research institutes and universities. Similarly, new research for hyperthermia is being undertaken. For instance,

In 2018, Chubu University, Nagoya City University, and Mitsubishi UFJ Capital commenced open innovation research on a novel cancer hyperthermia therapy. The research aimed to find and optimize magnetic nanoparticles with high capacity for delivery into tumors and then explore their application as a new hyperthermia therapy for cancer treatment.

Report Attributes	Details
Estimated Hyperthermia Cancer Treatment Market Value (2024E)	US$ 158.5 million
Projected Market Value (2034F)	US$ 285.1 million
Global Market Growth Rate (2024 to 2034)	6.0% CAGR
Microwave Devices Segment Market Share (2034)	39.7%
Prostate Cancer Segment Growth Rate (2024 to 2034)	7.2%
North America Market Share (2024)	44.7%
East Asia Market Share (2024)	6.1%
Key Companies Profiled	Celsius42+ GmbH Oncothermia Haifu Medical Technology Co. Ltd Pyrexar Medical Inc. Hydrosun GmbH Andromedic Srl Yamamoto Vinita Co., Ltd. Others

Hyperthermia Cancer Treatment Market Analysis:

Which Factors are Propelling Hyperthermia Cancer Treatment Demand?

“Rising Prevalence of Cancer Globally”

There has been a spike in cancer cases globally during the last few decades, and the trend is expected to further escalate during the forecast period. Cancer patients are seeking treatments that are non-invasive and have fewer less side effects. This is expected to fuel demand for hyperthermia therapy during the assessment period.

Used in combination with standard therapies like chemotherapy, hyperthermia represents a promising avenue for improving treatment outcomes. This non-invasive cancer therapy is becoming highly popular in patients demanding innovative and effective treatment options.

According to the World Health Organization (WHO), the number of people diagnosed with cancer is estimated to reach around 21.6 million by 2030. This will create growth prospects for the hyperthermia cancer treatment industry.

“Integration of Hyperthermia with Standard Cancer Treatments”

Hyperthermia alone is not therapeutically effective for all types of cancers. As a result, it is being integrated with standard cancer treatments like chemotherapy and radiation therapy. This synergistic approach has shown promising results in improving treatment effectiveness and lowering side effects.

Hyperthermia can significantly enhance the effectiveness of conventional cancer treatments by making tumor cells more susceptible to chemotherapy and radiation. Hence, the ability of hyperthermia therapy to make other cancer treatments more effective is expected to propel its demand during the forecast period.

What are the Key Hyperthermia Cancer Treatment Market Trends?

“Growing Need for Minimally Invasive Cancer Treatments”

Rising preference for minimally invasive cancer treatment options is emerging as a key trend boosting hyperthermia cancer treatment market growth. Similarly, advancements in minimally invasive hyperthermia technologies will bode well for the target market.

Patients worldwide prefer minimally invasive cancer treatments owing to their faster recovery times and fewer side effects. Hyperthermia aligns with this trend as it offers a non-invasive approach compared to radiation or surgery. Rising popularity of personalized medicine is also influencing hyperthermia cancer treatment industry growth.

“Ongoing Technological Advancements in Temperature-elevating Devices”

Continuous advancements in thermal regulation devices are improving their efficacy and precision. For instance, new technologies like targeted nanomaterial and minimally invasive probes allow for more accurate heat delivery to tumors while reducing exposure to healthy tissues.

Introduction of more precise and targeted hyperthermia technologies, including nanoparticle-mediated heating and radiofrequency, is anticipated to foster growth. Subsequently, advancements in imaging techniques like MRI-guided hyperthermia will benefit the market.

Which Factors are Limiting Market Expansion?

“High Cost and Side Effects of Hyperthermia Cancer Treatments”

Despite a robust growth trajectory, certain factors can limit growth of the global market. One such factor is the high cost of hyperthermia treatments.

Hyperthermia therapies are more costly than other cancer procedures. In most cases, hyperthermia therapy is taken as a combination therapy with chemotherapy or radiation. This makes it more expensive for cancer patients.

Another factor limiting market expansion is the side effects associated with hyperthermia treatment. Usage of hyperthermia therapy often results in side effects like pain, skin change, fatigue, infection, etc.

There is also lack of awareness about hyperthermia and its benefits in several regions. This can also negatively impact the target market. Further, high initial hyperthermia equipment costs might deter clinics and hospitals from adopting the technology.

Country-wise Insights

North America is expected to remain a dominant hyperthermia cancer treatment industry, while East Asia will likely present lucrative growth opportunities to hyperthermia device manufacturers. This is due to expanding healthcare infrastructure in these regions, rising incidence of cancer, and growing demand for novel cancer treatments.

The East Asia hyperthermia cancer treatment market is set to advance at a healthy CAGR of 7.2% during the assessment period. It will hold a revenue share of about 6.8% by the end of 2034, with Korea and Japan leading from the forefront.

The North America hyperthermia cancer treatment industry is estimated to grow at 5.6% CAGR over the assessment period. It is set to hold a global market share of 42.9% by 2034, with the United States emerging as the leading consumer of hyperthermia systems.

What Makes the United States a Prominent Hyperthermia Cancer Treatment Market?

“Rising Prevalence of Cancer Spurring Market Growth in the United States”

The United States hyperthermia cancer treatment market is anticipated to reach US$ 92 million in 2034. Over the assessment period, demand for hyperthermia treatment in the United States is set to grow at 5.4% CAGR.

Multiple factors are expected to stimulate growth of the hyperthermia cancer treatment market in the United States. These include increasing incidence of cancer, growing preference for minimally invasive cancer treatments, and presence of leading hyperthermia device manufacturers.

The United States is witnessing a sharp rise in cancer cases due to several factors. As per the American Cancer Society, around 1.9 million new cancer cases are anticipated to be diagnosed in the United States in 2023. This will create significant demand for cancer treatments like hyperthermia therapy and chemotherapy.

Another prominent factor improving the United States hyperthermia cancer treatment market share is the growing popularity of minimally invasive options. Patients across the nation are seeking less invasive cancer treatments. This is expected to fuel hyperthermia therapy demand and boost hyperthermia device sales.

How is Japan’s Hyperthermia Cancer Treatment Industry Shaping?

“Increasing Geriatric Population Facilitating Market Expansion in Japan”

Japan’s hyperthermia cancer treatment market is set to advance at a robust CAGR of 7.2% during the forecast period. Total revenue in Japan is projected to reach US$ 14 million by 2034. This is attributable to rising geriatric population, increasing cancer cases, and integration of hyperthermia with conventional cancer treatments.

Japan has a high proportion geriatric population, leading to an increased risk of cancer. As per the World Economic Forum, more than 1 in 10 people in Japan are aged 80 and above. This, in turn, is creating a larger pool of potential patients for hyperthermia treatments.

Advancements in hyperthermia equipment and technologies, including electromagnetic heating and focused ultrasound, are allowing players in Japan to make hyperthermia more appealing to healthcare providers as well as patients. This will further boost the hyperthermia cancer treatment market trends in the country.

Category-wise Insights:

The below section offers more profound insights into leading segments and their respective shares in the market for hyperthermia cancer treatment. Based on device type, the microwave hyperthermia device segment is set to lead the market for cancer therapeutics, holding a value share of 39.7% in 2034.

By application, breast cancer segment is poised to grow at a CAGR of around 5.9% between 2024 and 2034, holding a value share of 23.4%. Usage of thermotherapy devices will remain high in hospitals, contributing a prominent revenue share of 47.7% by 2034.

Which is the Most Popular Hyperthermia Device on the Market?

“Microwave Devices Remain Highly Sought-after Type”

As per the latest analysis, demand remains high for microwave devices in the market. This is because these devices provide a variety of heating approaches that can treat most cancers regardless of the size.

The microwave devices segment is poised to grow at 5.9% CAGR during the assessment period. It will likely total US$ 113.1 million by 2034 and hold a prominent value share of 39.7%.

Microwave devices use the heating properties of microwaves to deliver targeted thermal therapy to specific body areas. They have become a potentially powerful tool in cancer treatment globally.

Growing adoption of microwave devices to treat cancer is expected to boost the target segment. These devices are widely used as an adjunct therapy to cancer treatment. This is because they can significantly enhance the effectiveness of other cancer treatments, including radiotherapy and chemotherapy.

Multiple benefits of microwave devices are also encouraging their adoption across hospitals and other settings. These include high effectiveness and minimally invasive nature. Rising popularity of microwave hyperthermia as an ideal minimally invasive therapy for cancer treatment will further boost the target segment.

Which Application Segment will Contribute Most to the Market?

“Rising Breast Cancer Cases to Create Lucrative Growth Prospects for the Market”

Based on application, breast cancer segment is predicted to dominate the global hyperthermia cancer treatment industry throughout the forecast period. It will likely grow at a CAGR of around 5.9% through 2034, contributing a revenue share of 23.4%.

Rising prevalence of breast cancer globally is a key factor expected to boost the target segment. Similarly, growing popularity of hyperthermia therapy for treating breast cancer patients will benefit the segment.

According to the International Agency for Research on Cancer (IARC), breast cancer burden is expected to increase to more than 3 million new cases per year by 2040. This is expected to elevate demand for hyperthermia treatments as well as heat treatment equipment, thereby fostering segment growth.

Who is the Leading End User of Hyperthermic Treatment Devices?

“Adoption of Hyperthermia Systems Remain High in Hospitals”

Hospitals remain the leading end users of heat therapy equipment. This is attributable to rising number of hospitals globally, increasing patient footfall, and availability of advanced facilities in hospitals.

As per the latest report, the hospitals segment is anticipated to advance with a CAGR of 6.4% during the forecast period. By 2034, the target segment will likely hold a market share of 47.7%.

Patients usually opt for cancer diagnostic procedures and treatments in hospitals due to low costs and availability of advanced technologies and healthcare professionals. As a result, more and more hospitals are incorporating advanced hyperthermia systems, thereby fostering segment growth.

Competitive Landscape

Celsius42+ GmbH, Oncothermia, Haifu Medical Technology Co. Ltd, Pyrexar Medical Inc., Hydrosun GmbH, Andromedic Srl, and Yamamoto Vinita Co., Ltd. are few of the leading manufacturers of hyperthermia systems/devices.

Key hyperthermia equipment manufacturers are continuously innovating to develop advanced cancer treatment solutions. They are integrating novel technologies in their hyperthermia systems to make them appealing to end users.

Several hyperthermia system companies are also adopting strategies like distribution agreements, partnerships, facility expansions, collaborations, and acquisitions. These strategies will enable them to expand their footprint and significantly stay ahead of the competition.

Recent Hyperthermia Cancer Treatment Industry Developments :

• In April 2023, Pyrexar Medical announced the CE mark renewal of its product line of RF Hyperthermia systems, including the BSD-2000 3D/MR Deep Regional Hyperthermia System and the BSD-500 Superficial/Interstitial Hyperthermia System, among others.
• Oncotherm showcased its loco-regional hyperthermia device (EHY-2030) at the MEDICO 2023. The novel device comprises an integrated patient management system, a smart electrode system, and a user-friendly touchscreen display with full system control.
• In August 2022, a new Tumor Hyperthermia Center was established in China that will use Pyrexar BSD-2000 Deep Regional Hyperthermia System. This advanced hyperthermia system will be used to treat cancer tumors and aid radiotherapy and chemotherapy treatments.

Hyperthermia Cancer Treatment Market Segmentation

• By Device Type :

  • Microwave Hyperthermia Device
  • Ultrasound Hyperthermia Device
  • Infrared Hyperthermia Device
  • Short-wave Hyperthermia Device

• By Application :

  • Breast Cancer
  • Liver Cancer
  • Soft Tissue Sarcoma
  • Leukemia
  • Head and Neck Tumors
  • Prostate Cancer
  • Others

• By End User :

  • Hospitals
  • Clinics
  • Research Institutes
  • Cancer Centers
  • Others

• By Region :

  • North America
  • Europe
  • Latin America
  • East Asia
  • South Asia & Oceania
  • Middle East & Africa